{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-004066","form_type":"8-K","ticker":"XBIT","cik":"0001626878","company_name":"XBiotech Inc.","filed_at":"2025-06-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.110920+00:00","generated_at":"2026-05-18T22:39:59.744138+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"XBiotech appoints Dr. Thomas Kündig and Craig Rademaker to Board of Directors","bullets":["Dr. Thomas Kündig, Director of Dermatology at University Hospital Zurich, appointed to Board and Compensation Committee effective June 24, 2025.","Craig Rademaker, private equity leader with 25+ years in finance, appointed to Board and Audit Committee, effective same date.","Both appointments expire at the 2025 Annual General Meeting; committees now include Jan-Paul Waldin, Dr. Peter Libby, and the new members."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-004066","json":"https://secwatch.observer/filing/0001171843-25-004066.json","markdown":"https://secwatch.observer/filing/0001171843-25-004066.md","text":"https://secwatch.observer/filing/0001171843-25-004066.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1626878/000117184325004066/0001171843-25-004066-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1626878/000117184325004066/f8k_062425.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T22:39:59.744138+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}